The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImpact Health Regulatory News (IHR)

Share Price Information for Impact Health (IHR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 85.20
Bid: 85.00
Ask: 85.30
Change: 0.10 (0.12%)
Spread: 0.30 (0.353%)
Open: 86.50
High: 86.50
Low: 84.80
Prev. Close: 85.10
IHR Live PriceLast checked at -
Impact Healthcare REIT is an Investment Trust

To seek to provide Shareholders with an attractive return, principally in the form of quarterly income distributions and with the potential for capital and income growth through exposure to a diversified portfolio of Healthcare Real Estate Assets.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

INTEREST RATE CAP AND HEDGING UPDATE

18 Aug 2023 07:00

RNS Number : 7048J
Impact Healthcare REIT PLC
18 August 2023
 

The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, any member state of the European Economic Area (other than the Republic of Ireland or the Netherlands and then only to professional investors in such jurisdictions), Canada, Australia, Japan or the Republic of South Africa.

 

18 August 2023

Impact Healthcare REIT plc

("Impact" or the "Company" or, together with its subsidiaries, the "Group")

NEW £50 MILLION INTEREST RATE CAP AT 4%. 92% OF DRAWN DEBT IS NOW HEDGED

In the first half year results announcement on 9 August 2023, the Group indicated that it was looking to increase the level of hedging in place. The Board of Directors of Impact Healthcare REIT plc (ticker: IHR), is pleased to announce that it has completed this process, and the Group has purchased a new £50 million interest rate cap, which caps SONIA at 4.0% for two years expiring on 15 August 2025, at a cost of £1.76 million.

The Group has now hedged or fixed the interest rates on 92% (£175 million)1 of its current drawn debt of £191 million. The weighted average cost of drawn debt is 4.66%2 based on SONIA of 5.4%. At current hedging and drawn debt levels, an increase of 50 bps in SONIA will result in a 4 bps increase in the weighted average cost of drawn debt2.

The Group's gross loan to value ("LTV") ratio at 30 June 2023 was 28.5%. No further debt has been drawn at the date of this announcement.

FOR FURTHER INFORMATION, PLEASE CONTACT:

Impact Health Partners LLP

Via H/Advisors Maitland

Mahesh Patel

Andrew Cowley

David Yaldron

Jefferies International Limited

+44 20 7029 8000

Tom Yeadon

tyeadon@jefferies.com

Neil Winward

nwinward@jefferies.com

Ollie Nott

onott@jefferies.com

Winterflood Securities Limited

+44 20 3100 0000

Neil Langford

neil.langford@winterflood.com

Joe Winkley

joe.winkley@winterflood.com

H/Advisors Maitland (Communications advisor)

+44 7747 113 930

James Benjamin

impacthealth-maitland@h-advisors.global

Rachel Cohen

 

The Company's LEI is 213800AX3FHPMJL4IJ53.

 

Further information on Impact Healthcare REIT is available at www.impactreit.uk.

 

NOTES:

Impact Healthcare REIT plc is a specialist and responsible owner of care homes and other healthcare properties across the UK. Elderly care is an essential service and demand for it is high and continues to grow as the UK's population gets older. We work with our tenants so we can grow together and help them care for more people, while continuing to improve our homes for their residents.

 

We take a long-term view and look to generate secure and growing income. This has allowed us to provide our shareholders with attractive and rising dividends and the potential for capital growth.

 

The target total dividend for the year ending 31 December 2023 is 6.77 pence per share3, a 3.5% increase over the 6.54 pence in dividends paid per ordinary share for the year ended 31 December 2022.

 

The Group's Ordinary Shares were admitted to trading on the main market of the London Stock Exchange, premium segment, on 8 February 2019. The Company is a constituent of the FTSE EPRA/NAREIT index

1 £175 million of debt currently hedged from: £75 million of loan notes fixed at 3% expiring in 2035. £50 million interest rate cap at 3% expiring in January 2025. £50 million interest rate cap at 4% expiring in August 2025.

2 Weighted average cost of drawn debt is based on £191 million excluding arrangement fees and cost of interest rate caps. This reflects the ongoing cash cost of the drawn debt.

3 This is a target only and not a profit forecast. There can be no assurance that the target will be met and it should not be taken as an indicator of the Company's expected or actual results.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSFWFAWEDSEDA
Date   Source Headline
24th Apr 20199:41 amRNSHolding(s) in Company
23rd Apr 20199:43 amRNSPublication of Supplementary Prospectus
15th Apr 20197:00 amRNSPROPOSED PLACING OF ORDINARY SHARES
12th Apr 20197:00 amRNSAnnual Report & Accounts and Notice of AGM
28th Mar 20197:00 amRNSFull year results
26th Mar 20195:12 pmRNSNotice of Full year Results
18th Mar 20195:20 pmRNSHolding(s) in Company
15th Mar 20197:00 amRNSInvestment Adviser Appointed as AIFM
13th Mar 20194:35 pmRNSPublication of Supplementary Prospectus
7th Mar 20197:00 amRNSNew Loan Facility
5th Mar 20192:57 pmRNSResult of Meeting
1st Mar 20197:00 amRNSAppointment of Non-Executive Director
28th Feb 20199:33 amRNSHolding(s) in Company
11th Feb 20192:44 pmRNSPublication of a Prospectus
7th Feb 20193:37 pmRNSHolding(s) in Company
5th Feb 20197:00 amRNSPLACING PROGRAMME AND MIGRATION TO PREMIUM SEGMENT
30th Jan 20197:00 amRNSNAV, Dividend Declaration & Trading Update
29th Jan 20196:15 pmRNSHolding(s) in Company
7th Jan 20195:07 pmRNSHolding(s) in Company
30th Nov 20187:00 amRNSUPDATE ON PIPELINE ACQUISITIONS AND FUNDRAISING
13th Nov 20185:33 pmRNSMajor Holding(s) in Company
6th Nov 20187:00 amRNSAcquisition
2nd Nov 20187:00 amRNSAcquisition
24th Oct 20187:00 amRNSPipeline Acquisitions and Possible Fundraising
23rd Oct 20187:00 amRNSNAV, Dividend Declaration and Trading Update
21st Sep 20187:00 amRNSAcquisition
20th Aug 20187:00 amRNSKey Information Document ("KID")
9th Aug 20187:01 amRNSInterim Results for the period to 30 June 2018
9th Aug 20187:00 amRNSDividend Declaration
8th Aug 20187:00 amRNSNOTICE OF HALF YEAR RESULTS
6th Aug 20187:00 amRNSACQUISITIONS UPDATE
2nd Aug 20185:09 pmRNSHolding(s) in Company
25th Jul 20184:06 pmRNSHolding(s) in Company
18th Jul 20182:07 pmRNSDavid Brooks, Non-Executive Director
18th Jun 20187:00 amRNSNew Loan Facility
23rd May 20187:00 amRNSAcquisition
1st May 20189:23 amRNSHolding(s) in Company
30th Apr 20183:32 pmRNSHolding(s) in Company
27th Apr 20187:00 amRNSNet Asset Value and Dividend
27th Apr 20187:00 amRNSResult of AGM
20th Apr 20182:03 pmRNSHolding(s) in Company
26th Mar 20184:38 pmRNSNotice of AGM
26th Mar 20187:00 amRNSAcquisition
21st Mar 20187:00 amRNSFULL YEAR RESULTS
20th Mar 20182:17 pmRNSHolding(s) in Company
16th Mar 20184:34 pmRNSNotice of Results
14th Mar 20182:54 pmRNSHolding(s) in Company
13th Mar 20183:40 pmRNSHolding(s) in Company
2nd Mar 201811:00 amRNSHolding(s) in Company
7th Feb 20184:13 pmRNSNET ASSET VALUE AND DIVIDEND

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.